Rebeccamycin

Rebeccamycin

File:Rebeccamycin.png
Identifiers
IUPAC name 7,10-dichloro-8-(3,4-dihydroxy-6-(hydroxymethyl)-5-methoxytetrahydro-2H- pyran-2-yl)-8,9-dihydro-1H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-1,3(2H)-dione
CAS Number	93908-02-2
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C27H21Cl2N3O7
Molar mass	570.38

WikiDoc Resources for Rebeccamycin
Articles
Most recent articles on Rebeccamycin Most cited articles on Rebeccamycin Review articles on Rebeccamycin Articles on Rebeccamycin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Rebeccamycin Images of Rebeccamycin Photos of Rebeccamycin Podcasts & MP3s on Rebeccamycin Videos on Rebeccamycin
Evidence Based Medicine
Cochrane Collaboration on Rebeccamycin Bandolier on Rebeccamycin TRIP on Rebeccamycin
Clinical Trials
Ongoing Trials on Rebeccamycin at Clinical Trials.gov Trial results on Rebeccamycin Clinical Trials on Rebeccamycin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Rebeccamycin NICE Guidance on Rebeccamycin NHS PRODIGY Guidance FDA on Rebeccamycin CDC on Rebeccamycin
Books
Books on Rebeccamycin
News
Rebeccamycin in the news Be alerted to news on Rebeccamycin News trends on Rebeccamycin
Commentary
Blogs on Rebeccamycin
Definitions
Definitions of Rebeccamycin
Patient Resources / Community
Patient resources on Rebeccamycin Discussion groups on Rebeccamycin Patient Handouts on Rebeccamycin Directions to Hospitals Treating Rebeccamycin Risk calculators and risk factors for Rebeccamycin
Healthcare Provider Resources
Symptoms of Rebeccamycin Causes & Risk Factors for Rebeccamycin Diagnostic studies for Rebeccamycin Treatment of Rebeccamycin
Continuing Medical Education (CME)
CME Programs on Rebeccamycin
International
Rebeccamycin en Espanol Rebeccamycin en Francais
Business
Rebeccamycin in the Marketplace Patents on Rebeccamycin
Experimental / Informatics
List of terms related to Rebeccamycin

Overview

Rebeccamycin is a weak topoisomerase I inhibitor isolated from Streptomyces sp. structurally similar to staurosporine. Does not show any inhibitory activity against protein kinases. Shows significant antitumor properties in vitro (IC₅₀=480nM against mouse B16 melanoma cells and IC₅₀=500nM against P388 leukemia cells).

References

• Production and biological activity of rebeccamycin, a novel antitumor agent: J.A. Bush, et al.; J. Antibiot. (Tokyo) 40, 668 (1987)
• Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group F. Anizon, et al.; J. Med. Chem. 40, 3456 (1997)
• DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin: C. Bailly, et al.; Biochemistry 36, 3917 (1997)
• Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition: C. Bailly, et al.; Chem. Biol. 6, 277 (1999)